Recent Quotes (30 days)

You have no recent quotes
chg | %

Nuva Pharmaceuticals Inc  

(Public, CVE:NPH)   Watch this stock  
Find more results for CVE:APH
0.000 (0.00%)
Delayed:   12:24PM EDT
CVE data delayed by 15 mins - Disclaimer
Currency in CAD
Range     -
52 week 0.06 - 0.23
Open     -
Vol / Avg. 0.00/21,080.00
Mkt cap 4.41M
P/E     -
Div/yield     -
EPS -0.03
Shares 36.77M
Beta 1.16
Inst. own     -

Key stats and ratios

Q1 (Mar '14) 2013
Net profit margin - -
Operating margin - -
EBITD margin - -
Return on average assets -109.73% 69.08%
Return on average equity -143.11% -
CDP Score - -


#615, 800 West Pender Street
+1-604-6872038 (Phone)
+1-604-6873141 (Fax)

Website links


Nuva Pharmaceuticals Inc., formerly ALDA Pharmaceuticals Corp., is engaged in the business of developing infection control products for industrial and consumer use and for the treatment of topical infections. The Company´┐Żs first product, a surface disinfectant called T36 Disinfex. It is being sold primarily to First Responder organizations, including ambulance, fire fighters and police forces in Canada; dental clinics, and beauty and hair care salons and spas. T36 Disinfex is a mixture of ethanol, o-phenylphenol, benzalkonium chloride and other ingredients (including lemon fragrance and water). All of these component chemicals are bio-degradable. The Company is also engaged in the development of other products, such as T36 Disinfex, T36 Disinfex Disinfectant Cleaner Wipes, T36 Disinfectant Cleaner CONCENTRATE, T36 Antiseptic Hand Sanitizer Gel, Liquids and Wipes, T36 Medicated Hand Cleanser, T36 Anti-viral Soap, T36 Microbicide Gel, T36 Skin antiseptic and first-aid ointment.

Officers and directors

Arun D. Nayyar Chief Executive Officer
Jamie A. Lewin Chief Financial Officer, Secretary, Director
Eugene Beukman Secretary, Independent Director
Sina Pirooz Director
Thomas J. Kennedy Independent Director